Advances in the Management of Gastrointestinal Cancers

1. Advances in the Management of Gastrointestinal Cancers November 2, 2013Somerset Inn HotelTroy, Michigan

2. Welcome • Michael Wiemann, MD, FACP • Senior Vice President • St. John Providence Health System President, Providence Hospital

3. Invocation Sr. Xavier Ballance, DC, FACHE Special Advisor to the SJPHS Senior Vice President

4. Introduction • Laurence Cheung, MD • Chairman, Department of Surgery Providence Hospital Providence Park Hospital

5. Conference Overview • Course Directors • Roberto Gamarra, MD, FACG, FACP • Michael Jacobs, MD, FACS, FICS • Advances in the Management of Gastrointestinal Cancers Conference. Today we will focus on risk factors, new screening techniques, best treatment strategies and the importance of coordinated multidisciplinary care in the treatment of Gastrointestinal Cancers.

6. Conference Syllabus • Conference materials available online only at http://www.stjohnprovidence.org/GIConference • Click on conference presentations

7. Disclosure • Consistent with the ACCME standards of Commercial Support, speakers for the conference are expected to disclose to you at the beginning of their presentation(s) whether or not they have any economic or other personal interests that create, or may be perceived as creating, a conflict related to the material discussed. This policy is intended to make you aware of speaker’s interests, so you may form your own judgments about such material

8. Faculty Disclosure Information • It is the intent of Providence Hospital and Medical Centers to assure that its CME activities are not influenced by the special interests of individuals associated with its programs. Having an interest in or an affiliation with any corporate organization does not necessarily influence a speaker’s presentation, but the relationship must be made known in advance to the audience in accordance with the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education. It is the policy of Providence Hospital and Medical Centers that faculty disclose all relationships with manufacturers of products or services discussed in their presentation. Faculty are also informed that they must disclose to the audience any discussion of off-label or investigational use of pharmaceuticals or medical devices that will be discussed during their presentation. Faculty for this program disclosed the following financial relationships:

9. Faculty Disclosure Information • Vanessa Boyce, MD Dr. Boyce disclosed she has no significant relationship with commercial supporters and no significant financial interest • June Chan, MD Dr. Chan disclosed she has no significant relationship with commercial supporters and no significant financial interest • Amir Damadi, MD Dr. Damadi disclosed he has no significant relationship with commercial supports and no significant financial interest • Ernesto Drelichman, MD Dr. Drelichman disclosed he has no significant relationship with commercial supporters and no significant financial interest • Roberto Gamarra, MD Dr. Gamarra disclosed he has no significant relationship with commercial supporters and no significant financial interest.

10. Faculty Disclosure Information • Michael Jacobs, MD Dr. Jacobs disclosed he has no significant relationship with commercial supporters and no significant financial interest • Denis Lincoln, MD Dr. Lincoln disclosed he has no significant relationship with commercial supporters and no significant financial interest • Janak Parikh, MD, MSHS Dr. Parikh disclosed he has no significant relationship with commercial supporters and no significant financial interest • Mark Zalupski, MD Dr. Zalupski disclosed he has no significant relationship with commercial supports and no significant financial interest

11. Faculty Disclosure Information • Hideki Hayashi, MD Dr. Hayashi disclosed Grant Research with Ethicon Endo-Surgery Japan and Covidien Japan, Inc. • Michael Kraut, MD Dr. Kraut has disclosed -Lilly Oncology speaker bureau • Shyam Varadarajulu, MD Dr. Varadarajuly disclosed Consultant Boston Scientific and Olympus

12. Conference Agenda Session A: Hepatic Malignancies Richard Berri, MD, Moderator • 8:05 am – 8:25 am Multidisciplinary Management of Hepatic Metastases Michael Kraut, MD, FACP • 8:25 am – 8:50 am Advanced Laparoscopic Liver Resection Michael Jacobs, MD, FACS, FICS • 8:50 am – 9:15 am Radiotherapy for Liver Malignancies June Chan, MD • 9:15 am – 9:40 am Interventional Radiology Liver Directed Therapies • ` Denis Lincoln, MD • 9:40 am – 9:45 am Panel Discussion/Q & A • 9:45 am – 9:50 am Award of Appreciation • 9:50 am – 10:00 am Break

13. Conference Agenda Session B: Updates on Pancreatic Cancer Moderator – Robert Bloom, MD • 10:00 am – 10:25 am Pancreatic Cancer Screening – Myth or Manna? Roberto Gamarra, MD. FACG, FACP • 10:25 am – 10:55 am Systemic Therapy for Pancreatic Cancer Mark Zalupski, MD • 10:55 am – 11:20 am Advanced Surgical Techniques for Pancreatic Cancer Janak Parikh, MD, MSHS •  11:20 am – 11:50 am EUS and ERCP in Pancreatic Cancer Shyam Varadarajulu, MD • 11:50 am – 12:00 pm Panel Discussion/Q & A • 12:15 pm – 1:00 pm Keynote Speaker/Lunch Laparoscopic Resection of Gastric Cancer: The Japanese Experience Hideki Hayashi, MD, PhD

14. Conference Agenda Session C: Hot Topics in Colorectal Cancer Moderator – Ralph Pearlman, MD • 1:15 pm – 1:40 pm Minimally Invasive Surgery for Colorectal Cancer Amir Damadi, MD • 1:40 pm – 2:05 pm Colorectal Cancer Prevention and Health Disparities Ernesto Drelichman, MD • 2:05 pm – 2:35 pm Updates in Colon Cancer Screening Jay Levinson, MD • 2:35 pm – 3:00 pm Palliative Care Options for Gastrointestinal Cancers Vanessa Boyce, MD • 3:00 pm – 3:10 pm Panel Discussion/Q & A

15. Planning Committee • Laurence Cheung, MD • Amir Damadi, MD • Ernesto Drelichman, MD • Roberto Gamarra, MD • Michael Jacobs, MD • Lauri Bolo, NP • Shelley Corp, RN • Michael Kraut, MD • Susan Markowicz, NP • Lou Martin • Bonnie Oke • Gayle Blakely

16. Volunteers • Debbie Beattie, RN • Karen Fife, RN • Kathy Honsowetz • Ting Jin, RN • Vanessa Reyes, RN • Sarah Sobieralski, RN • Laura Dailey-Pelle, MSA, RTT

17. Exhibitors We would like to thank our exhibitors: • AbbVie • Astellas • Genentech • Bristol Myers Squibb • Providence Hospital Department of Surgery • Genomic Health • Boston Scientific

18. Accreditation • Providence Hospital and Medical Centers is accredited by the Michigan State Medical Society Committee on CME Accreditation to provide continuing medical education for physicians. Providence Hospital and Medical Centers designates this educational activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. • St. John Providence Health System (OH-287, 7/1/2015) is an approved provider of continuing nursing education by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 6.16 Contact Hours will be awarded to nurses who attend the program • This activity is approved for 7.5 credit by the ASRT.

19. Certificate of Attendance • Certificates (ASRT, CME, Contact Hours) will be exchanged for completed evaluationsat the end of the conference!

20. Breaks/Lunch • Rest Rooms are located just right of the registration tables. • Lunch will be held in this room.

21. Phones and Pagers Please set your phones and pagers to silent or vibrate